Free Trial
LON:4BB

4basebio (4BB) Share Price, News & Analysis

4basebio logo
GBX 920 +35.00 (+3.95%)
As of 10:46 AM Eastern

About 4basebio Stock (LON:4BB)

Key Stats

Today's Range
850
920
50-Day Range
850.70
1,028
52-Week Range
850
1,537.20
Volume
517 shs
Average Volume
1,130 shs
Market Capitalization
£117.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 1,600
Consensus Rating
Buy

Company Overview

4basebio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
35th Percentile Overall Score

4BB MarketRank™: 

4basebio scored higher than 35% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    4basebio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    4basebio has received no research coverage in the past 90 days.

  • Read more about 4basebio's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of 4basebio is -1,179.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of 4basebio is -1,179.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for 4BB.
  • Dividend Yield

    4basebio does not currently pay a dividend.

  • Dividend Growth

    4basebio does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for 4BB.
  • News Sentiment

    4basebio has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for 4basebio this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, 4basebio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    68.44% of the stock of 4basebio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 2.04% of the stock of 4basebio is held by institutions.

  • Read more about 4basebio's insider trading history.
Receive 4BB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

4BB Stock News Headlines

4BASEBIO UK SOCIETAS (4BB) - Investing.com UK
What Are Some Strategies to Help Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.tc pixel
4basebio Plc - Director Appointment, Board Change
See More Headlines

4BB Stock Analysis - Frequently Asked Questions

4basebio's stock was trading at GBX 1,210 at the beginning of the year. Since then, 4BB stock has decreased by 24.0% and is now trading at GBX 920.

4basebio PLC (LON:4BB) posted its quarterly earnings results on Tuesday, May, 27th. The company reported ($0.94) earnings per share (EPS) for the quarter.

Shares of 4BB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that 4basebio investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX).

Company Calendar

Last Earnings
5/27/2025
Today
8/28/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:4BB
CIK
N/A
Fax
N/A
Employees
101
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 1,600
Low Price Target
GBX 1,600
Potential Upside/Downside
+73.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (0.78)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£9.84 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-231.29%
Return on Assets
-54.30%

Debt

Debt-to-Equity Ratio
201.47
Current Ratio
2.73
Quick Ratio
3.52

Sales & Book Value

Annual Sales
£311 thousand
Price / Sales
378.95
Cash Flow
GBX 57.22 per share
Price / Cash Flow
16.08
Book Value
GBX (41) per share
Price / Book
-22.44

Miscellaneous

Outstanding Shares
12,810,000
Free Float
N/A
Market Cap
£117.85 million
Optionable
Not Optionable
Beta
1.09
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (LON:4BB) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners